Doximity, Inc.
DOCS
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 33.62 | -30.80% |
| 2025 | 48.58 | 42.75% |
| 2024 | 34.03 | -38.62% |
| 2023 | 55.44 | 0.77% |
| 2022 | 55.02 | -70.75% |
| 2021 | 188.11 | -41.91% |
| 2020 | 323.85 | -73.66% |
| 2019 | 1.23K | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 19.68 | -41.47% |
US
|
|
| 64.40 | 91.57% |
AU
|
|
| 44.30 | 31.78% |
US
|
|
| -47.78 | -242.11% |
US
|
|
| -123.90 | -468.55% |
US
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.